Today

Agents

Chat

Arena

Discover

More

App

Outlook Therapeutics names Kevin Lundquist CFO - OTLK News | Rallies

Outlook Therapeutics names Kevin Lundquist CFO

OTLK•2026-10-06

Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it shifts to a commercial-stage launch of LYTENAVA.

1. CFO appointment

Outlook Therapeutics appointed Kevin Lundquist as chief financial officer as it shifts to a commercial-stage launch of LYTENAVA.

Related News

S&P 500, Nasdaq touch new peaks as Treasury yields cool, oil slips

SPY•2026-10-06

Canada's TSX edges up as bond yields retreat, utility shares advance

EWC•2026-10-06

IMF says hedge funds' market footprint growing, merits closer scrutiny

2026-10-06

Mattel dips as Ariel pushes for sale, citing stalled turnaround

MAT•2026-10-06

eToro analysis shows tech, gaming portfolios return 1,342% and 1,252% over decade, beating Nasdaq-100's 636%

ETOR•2026-10-06